-
公开(公告)号:FI925370A0
公开(公告)日:1992-11-26
申请号:FI925370
申请日:1992-11-26
Applicant: HOECHST AG
Inventor: FRICK WENDELIN , MUELLER GUENTER , MUELLNER STEFAN , BREIPOHL GERARD
IPC: A61K38/28 , A61K38/00 , A61P3/08 , A61P3/10 , C07K5/06 , C07K5/065 , C07K5/08 , C07K5/087 , C07K5/093 , C07K5/097 , C07K7/06 , C07K7/08 , C07K9/00
Abstract: Peptides with insulin-like activity and the formula I where C is a hydrogen atom, amino-acid residue, substituted amino-acid residue or sugar residue, D is an amino-acid residue, phosphoamino-acid residue, sugar residue, covalent bond or hydroxyl radical, E is a hydrogen atom, hydroxyl radical, substituted sugar residues, substituted alkyldiamine or glycerol residue, R is (C1-C4)-alkyl, =O or -O-(C1-C4)-alkyl, R is a sulphur protective group, SO2, SO3, (C1-C3)-alkyl, O2 radical, O3 radical, or hydrogen atom, R or R is, independently of one another, hydrogen or methyl, and W is an integer 1 or 2, the preparation and use thereof for the treatment of diabetes mellitus or non-insulin-dependent diabetes are described.
-
公开(公告)号:FI923702A0
公开(公告)日:1992-08-18
申请号:FI923702
申请日:1992-08-18
Applicant: HOECHST AG
Inventor: MUELLER GUENTER , TRIPIER DOMINIQUE , MUELLNER STEFAN
IPC: A61K38/28 , A61K31/715 , A61K38/00 , A61P3/08 , A61P3/10 , C07K1/22 , C07K5/08 , C07K5/093 , C07K5/10 , C07K9/00 , C07K14/37 , C07K14/41 , C07K14/475 , C07K14/575 , C07K14/62 , C07K14/65 , C12P19/26 , C12P21/00 , C12P21/02 , C12R1/865 , C12P
Abstract: Phosphoinositolglycan peptides, obtainable by cleavage of adenosine-3%,5%-cyclic monophosphate binding protein, which contain glucosamine, galactose, mannose, inositol, phosphoric acid, ethanolamine and a peptide containing the sequence Asn-Cys-Tyr, their preparation and use for the treatment of diabetes mellitus and non-insulin-dependent diabetes are described.
-
公开(公告)号:MX9200333A
公开(公告)日:1992-08-01
申请号:MX9200333
申请日:1992-01-27
Applicant: HOECHST AG
Inventor: AIGNER RUDOLF , MUELLER GUENTER , SCHOLZ HANS JUERGEN , WEHLE DETLEF
IPC: C07C213/02 , C07C213/04 , C07C215/10 , C07C213/08
Abstract: The novel process is based on the reaction of a dialkylamine, preferably dimethylamine or diethylamine, with a monohalopropanediol, preferably monochloropropanediol, in the presence of water. The reaction is carried out in the presence of 25 to 70% by weight of water and at a temperature of from 20 to 80 DEG C, the dialkylamine being employed in an amount of at least 2.5 mol per mol of monohalopropanediol. The novel process allows a high space-time-yield and also a high chemical yield of virtually pure dialkylaminopropanediol to be obtained.
-
公开(公告)号:NO914999D0
公开(公告)日:1991-12-18
申请号:NO914999
申请日:1991-12-18
Applicant: HOECHST AG
Inventor: MUELLNER STEFAN , KOENIG WOLFGANG , MUELLER GUENTER
IPC: A61K38/00 , A61K38/06 , A61K38/08 , A61K38/28 , A61P3/08 , A61P3/10 , A61P43/00 , C07K1/113 , C07K5/08 , C07K5/087 , C07K5/10 , C07K7/00 , C07K7/06 , C07K14/62 , C07K
Abstract: Short peptides of the formula I X-Y-A-B-C-Cys-D-E (I> in which A and B are an amino acid or a covalent bond, C and D are an amino acid or a substituted amino acid, E is a modified or unmodified amino acid or a covalent bond, X is a radical or hydrogen and Y is leucine or a covalent bond, or dimers of the peptides of the formula I with cystine as dimerisation component, the stereoisomeric forms thereof where appropriate or their physiologically tolerated salts, the preparation thereof, and their use for the treatment of diabetes mellitus are described.
-
公开(公告)号:NO309146B1
公开(公告)日:2000-12-18
申请号:NO924585
申请日:1992-11-27
Applicant: HOECHST AG
Inventor: FRICK WENDELIN , MUELLER GUENTER , MUELLNER STEFAN , BREIPOHL GERHARD
IPC: A61K38/00 , A61K38/28 , A61P3/08 , A61P3/10 , C07K5/06 , C07K5/065 , C07K5/08 , C07K5/087 , C07K5/093 , C07K5/097 , C07K7/06 , C07K7/08 , C07K9/00
Abstract: Peptides with insulin-like activity and the formula I where C is a hydrogen atom, amino-acid residue, substituted amino-acid residue or sugar residue, D is an amino-acid residue, phosphoamino-acid residue, sugar residue, covalent bond or hydroxyl radical, E is a hydrogen atom, hydroxyl radical, substituted sugar residues, substituted alkyldiamine or glycerol residue, R is (C1-C4)-alkyl, =O or -O-(C1-C4)-alkyl, R is a sulphur protective group, SO2, SO3, (C1-C3)-alkyl, O2 radical, O3 radical, or hydrogen atom, R or R is, independently of one another, hydrogen or methyl, and W is an integer 1 or 2, the preparation and use thereof for the treatment of diabetes mellitus or non-insulin-dependent diabetes are described.
-
公开(公告)号:HU9702242A2
公开(公告)日:1998-12-28
申请号:HU9702242
申请日:1997-11-26
Applicant: HOECHST AG
Inventor: FRICK WENDELIN , MUELLER GUENTER
IPC: C07H15/207 , A61K31/70 , A61K31/7028 , A61K31/7034 , A61K31/715 , A61K31/716 , A61K38/28 , A61P3/08 , A61P3/10 , A61P5/00 , A61P5/48 , C07H3/04 , C07H3/06 , C07H11/04 , C07H15/203 , C08B37/00 , C07H15/02
Abstract: Inositol glycan derivatives of formula (I), their salts and stereoisomeric forms, are new: A-Z-R (I) A = HP(=O)(OH), HP(=S)(OH), HOP(=S)(OH), HSP(=S)(OH), (1-4C alkyl)P(=O)(OH), (1-4C alkyl)P(=S)(OH), SO2ORl, S(=O)OR1, NH2CO, NR1R2, R1R2NCONH, R1OSO2NH, (1-4C alkyl)SO2, (1-4C alkyl)S(=O) or R1S; R1, R2 = H or 1-4C alkyl; Z = 2-6 sugar residues (optionally substituted by up to 6 Me, sugar residue, di-sugar residue, SO2OH, CONR1R2, CO(1-4C alkyl), P(=O)(H)OH, P(=O)(OH)2, P(=S)(H)OH, P(=S)(OH)2, P(=S)(SH)(OH), P(=O)(OH)OCH2CH2NR1R2), or the glycosidic bridge between the 2-6 sugar residues may be 1-6 fold replaced by CH2 or S; R = inositol, inositol phosphate, inositol thiophosphate, inositol cyclo-phosphate, inositol cyclo-thiophosphate (optionally substituted by 1-2 phosphate or thiophosphate, or single substitution by cyclo-phosphate or cyclo-thiophosphate), or inositol (where two neighbouring OH groups are replaced by CH2SO2NH).
-
公开(公告)号:NO303452B1
公开(公告)日:1998-07-13
申请号:NO923252
申请日:1992-08-19
Applicant: HOECHST AG
Inventor: MUELLER GUENTER , TRIPIER DOMINIQUE , MUELLNER STEFAN
IPC: A61K38/28 , A61K31/715 , A61K38/00 , A61P3/08 , A61P3/10 , C07K1/22 , C07K5/08 , C07K5/093 , C07K5/10 , C07K9/00 , C07K14/37 , C07K14/41 , C07K14/475 , C07K14/575 , C07K14/62 , C07K14/65 , C12P19/26 , C12P21/00 , C12P21/02 , C12R1/865
Abstract: Phosphoinositolglycan peptides, obtainable by cleavage of adenosine-3%,5%-cyclic monophosphate binding protein, which contain glucosamine, galactose, mannose, inositol, phosphoric acid, ethanolamine and a peptide containing the sequence Asn-Cys-Tyr, their preparation and use for the treatment of diabetes mellitus and non-insulin-dependent diabetes are described.
-
公开(公告)号:AU4458697A
公开(公告)日:1998-04-14
申请号:AU4458697
申请日:1997-09-15
Applicant: HOECHST AG
Inventor: MUELLER GUENTER , PREIBISCH GERALD , ERTL JOHANN
IPC: C12N15/09 , A61K38/00 , A61K38/17 , A61K38/22 , A61K45/00 , A61P3/10 , A61P5/50 , C07K14/575 , C07K16/26 , C07K19/00 , C12P21/02
Abstract: The invention relates to pharmaceutical agents containing leptin antagonists for treating Type II diabetes. One leptin antagonist is based on a murine leptin fragment and comprises amino acids 116 to 167 or 116 to 166. Methods of treating Type II diabetes are also disclosed.
-
公开(公告)号:HU9702242D0
公开(公告)日:1998-03-02
申请号:HU9702242
申请日:1997-11-26
Applicant: HOECHST AG
Inventor: FRICK WENDELIN , MUELLER GUENTER
IPC: C07H15/207 , A61K31/70 , A61K31/7028 , A61K31/7034 , A61K31/715 , A61K31/716 , A61K38/28 , A61P3/08 , A61P3/10 , A61P5/00 , A61P5/48 , C07H3/04 , C07H3/06 , C07H11/04 , C07H15/203 , C08B37/00
Abstract: Inositol glycan derivatives of formula (I), their salts and stereoisomeric forms, are new: A-Z-R (I) A = HP(=O)(OH), HP(=S)(OH), HOP(=S)(OH), HSP(=S)(OH), (1-4C alkyl)P(=O)(OH), (1-4C alkyl)P(=S)(OH), SO2ORl, S(=O)OR1, NH2CO, NR1R2, R1R2NCONH, R1OSO2NH, (1-4C alkyl)SO2, (1-4C alkyl)S(=O) or R1S; R1, R2 = H or 1-4C alkyl; Z = 2-6 sugar residues (optionally substituted by up to 6 Me, sugar residue, di-sugar residue, SO2OH, CONR1R2, CO(1-4C alkyl), P(=O)(H)OH, P(=O)(OH)2, P(=S)(H)OH, P(=S)(OH)2, P(=S)(SH)(OH), P(=O)(OH)OCH2CH2NR1R2), or the glycosidic bridge between the 2-6 sugar residues may be 1-6 fold replaced by CH2 or S; R = inositol, inositol phosphate, inositol thiophosphate, inositol cyclo-phosphate, inositol cyclo-thiophosphate (optionally substituted by 1-2 phosphate or thiophosphate, or single substitution by cyclo-phosphate or cyclo-thiophosphate), or inositol (where two neighbouring OH groups are replaced by CH2SO2NH).
-
公开(公告)号:CA2197276A1
公开(公告)日:1997-08-13
申请号:CA2197276
申请日:1997-02-11
Applicant: HOECHST AG
Inventor: SIEVERS WERNER , MUELLER GUENTER
Abstract: The invention relates to a fluidized-bed scrubber containing fluidizingbodies for purifying gases and to processes for its operation. The invention enables the fluidized-bed scrubber to be dimensioned, and the processes to be carried out, in such a manner that the number of fluidizing bodies is minimized and as much energy as possible is saved, without this decreasing the purifying efficiency.
-
-
-
-
-
-
-
-
-